GE HealthCare has received the US Food and Drug Administration (FDA) approval for Flyrcado (flurpiridaz F-18), a breakthrough PET radiotracer poised to transform the diagnosis of coronary artery disease (CAD). This novel radiopharmaceutical offers higher diagnostic efficacy compared to the current standard, single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). CAD remains the leading […]
In a landmark achievement for cardiovascular medicine, Sahajanand Medical Technologies has announced the successful completion of patient enrolment for the TUXEDO-2 clinical trial in India. This pivotal study is set to explore the effectiveness and safety of the Supraflex Cruz Drug-Eluting Stent (DES) in diabetic patients suffering from multivessel coronary artery disease (CAD). The TUXEDO-2 […]
HeartFlow, Inc., a leading innovator in non-invasive artificial intelligence (AI) solutions for heart care, has launched its next-generation HeartFlow Plaque Analysis platform. This advanced tool, unveiled at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C., represents a significant leap forward in coronary artery disease (CAD) risk assessment and personalized patient […]
Concept Medical has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for its Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). Superficial Femoral Arteries (SFA) are blood vessels located in the thigh region that supply blood to the lower extremities. They are commonly […]
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, plus potential contingent payment on regulatory submission of the latter’s baxdrostat product. Under the merger agreement, the British-Swedish biotechnology company will initiate a tender offer by 23 January 2023 to […]
Bracco Diagnostics, the US subsidiary of Italian diagnostic imaging company Bracco Imaging, has secured approval from the US Food and Drug Administration (FDA) for its new CardioGen-82 infusion system. According to Bracco Diagnostics, CardioGen-82 infusion system is used for improving automation, efficiency, and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging (MPI). CARDIOGEN-82 […]
